» Articles » PMID: 17033159

Hearing in Patients with Intracanalicular Vestibular Schwannomas

Overview
Publisher Karger
Date 2006 Oct 13
PMID 17033159
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

This paper reports data on the spontaneous course of hearing in 156 patients with purely intracanalicular vestibular schwannomas. The mean pure tone average (PTA) was 51 dB HL and the mean speech discrimination score (SDS) 60% at diagnosis. The risk of a significant subsequent hearing loss (>or=10 dB PTA or >or=10% SDS) was 54% during 4.6 years of observation. Patients with normal speech discrimination at diagnosis had a significantly smaller risk of loosing hearing. The hearing loss at diagnosis and during observation was not related to age, gender, diagnostic tumor size, tumor- induced expansion of the internal auditory canal or tumor sublocalization (fundus, central or porus). However, the loss of PTA was smaller in shrinking tumors and the PTA deterioration rate correlated with the volumetric tumor growth rate. After 4.6 years observation, the PTA had increased by 14 dB to 65 dB HL, and the SDS reduced by 17% to 43%. The proportion of patients eligible for hearing preservation treatment as determined by word recognition score class I (70-100% SDS) was reduced to 28% (a 44% reduction), and by AAO-HNS class A to 9% (a 53% reduction).

Citing Articles

A Proposal for Comprehensive Audio-Vestibular Test Battery Protocol for Diagnosis and Follow-Up Monitoring in Patients with Vestibular Schwannoma Undergoing Surgical Tumor Removal.

Torchalla P, Jasinska-Nowacka A, Lachowska M, Niemczyk K J Clin Med. 2024; 13(17).

PMID: 39274220 PMC: 11396387. DOI: 10.3390/jcm13175007.


Reported Hearing Outcome Measures Following Stereotactic Radiosurgery for Vestibular Schwannoma: A Scoping Review.

Almufarrij I, Hannan C, King A, Vail A, Heal C, Whitfield G J Neurol Surg B Skull Base. 2024; 85(2):123-130.

PMID: 38449586 PMC: 10914468. DOI: 10.1055/a-2021-8762.


miR-431 secreted by human vestibular schwannomas increases the mammalian inner ear's vulnerability to noise trauma.

Fujita T, Seist R, Kao S, Soares V, Panano L, Khetani R Front Neurol. 2023; 14:1268359.

PMID: 37885485 PMC: 10598552. DOI: 10.3389/fneur.2023.1268359.


The genetic landscape and possible therapeutics of neurofibromatosis type 2.

Ghalavand M, Asghari A, Farhadi M, Taghizadeh-Hesary F, Garshasbi M, Falah M Cancer Cell Int. 2023; 23(1):99.

PMID: 37217995 PMC: 10204202. DOI: 10.1186/s12935-023-02940-8.


Sporadic Vestibular Schwannoma Size and Location Do not Correlate With the Severity of Hearing Loss at Initial Presentation.

Brown A, Early S, Vasilijic S, Stankovic K Front Oncol. 2022; 12:836504.

PMID: 35372070 PMC: 8965062. DOI: 10.3389/fonc.2022.836504.